Aprecap 150 I. V.

Aprecap 150 I. V. Specification

Pacakaging (Quantity Per Box)
1 vial per box

Life Span
Check expiry on pack

Brand Name
Aprecap I.V.

Salt Composition
Fosaprepitant Dimeglumine 150mg

Indication
Prevention of chemotherapy-induced nausea and vomiting (CINV)

Origin of Medicine
India

Dosage Form
Parenteral (Injection)

Packaging Type
Vial in box

Drug Type
Prescription only medicine

Ingredients
Fosaprepitant Dimeglumine

Physical Form
Injection / I.V.

Function
Antiemetic (prevents nausea/vomiting)

Recommended For
For intravenous use only, as per physicians advice

Dosage
As directed by physician

Dosage Guidelines
Administer intravenously as per instructions

Suitable For
Adults

Quantity
150 mg/vial

Storage Instructions
Store below 30C

Administration Route
Intravenous (I.V.)

Therapeutic Class
Antiemetic

Prescription Status
Prescription required

Reconstitution Required
Yes, as per manufacturer's instructions

Contraindications
Known hypersensitivity to fosaprepitant or any component

Batch No.
Refer to product packaging

Appearance
Sterile, lyophilized powder

Caution
Use under strict medical supervision

Aprecap 150 I. V. Trade Information

Minimum Order Quantity
10 Pieces

Delivery Time
5-7 Days

About Aprecap 150 I. V.

Discover the classic, praiseworthy excellence of Aprecap 150 I.V., an elite antiemetic designed for hospital use only. This exquisite product contains Fosaprepitant Dimeglumine (150mg) as a sterile powder requiring reconstitution before administration. Recommended exclusively for adults under prescription, it is available in single vials and must be delivered intravenously as directed by a physician. Engineered to prevent chemotherapy-induced nausea and vomiting, Aprecap 150 I.V. promises efficacy and reliability. Grab yours today to secure a bargain in top-tier patient care-true mastery from India's pharmaceutical sector.

Aprecap 150 I.V.: Type, Specific Usage & Application

Aprecap 150 I.V. is strictly for intravenous use under medical supervision. Crafted for the prevention of chemotherapy-induced nausea and vomiting, its usage is confined to hospital settings and guided by healthcare professionals. This parenteral injection, presented as a sterile powder for reconstitution, must be prepared and administered according to the physician's directions to ensure optimal effect. Suitable for adult patients only, this medication underlines the importance of following precise clinical protocols for safe and effective therapy.

Logistics, Export Markets & Supply of Aprecap 150 I.V.

Aprecap 150 I.V. is exported to various international markets with a focus on cost-effective expenditure management for healthcare providers. Orders are meticulously dispatched from India's leading supply hubs, ensuring swift and reliable logistics. With a strong supply ability, the product is readily available to meet global demand. Shipments are processed from the designated FOB ports in India, where careful consideration is given to packaging and compliance, guaranteeing the medicine reaches its destination in excellent condition.

FAQ's of Aprecap 150 I. V.:

Q: How should Aprecap 150 I.V. be administered?

A: Aprecap 150 I.V. must be reconstituted and administered intravenously by a healthcare professional, strictly following the physician's instructions in a hospital setting.

Q: What is the main indication for using Aprecap 150 I.V.?

A: Aprecap 150 I.V. is used to prevent nausea and vomiting associated with chemotherapy in adults. It is an antiemetic dedicated to managing chemotherapy-induced symptoms.

Q: When should Aprecap 150 I.V. be used during chemotherapy treatment?

A: Aprecap 150 I.V. should be administered shortly before chemotherapy sessions begin, as directed by the prescribing physician to maximize its effectiveness in controlling symptoms.

Q: Where can Aprecap 150 I.V. be obtained?

A: Aprecap 150 I.V. is a prescription-only medicine supplied through authorized hospitals and pharmacies, and should only be used under medical supervision.

Q: What is the process for preparing Aprecap 150 I.V. for use?

A: Before administration, Aprecap 150 I.V. must be reconstituted by dissolving the sterile powder in an appropriate solvent, as per the instructions provided by the manufacturer and healthcare provider.

Q: What are the benefits of choosing Aprecap 150 I.V. for patients undergoing chemotherapy?

A: Aprecap 150 I.V. offers praiseworthy efficacy in preventing nausea and vomiting induced by chemotherapy, improving the patient's comfort and compliance with cancer treatment protocols.